The Lancet · By Dr. María Victoria Ibáñez-Soto · Sunday, August 9, 2026
Embryonic engineering and the commodification of the human genome
The Lancet publishes a meta-analysis on the clinical application of CRISPR-Cas9 gene editing in the embryonic germline in lax regulatory jurisdictions. The report warns about the exponential increase in clinics that offer 'aesthetic and cognitive genetic improvement' at exorbitant costs, generating a debate about the possible biological bifurcation of the species. Multiple off-target anomalies are reported that compromise embryo viability and unpredictably alter the proteome.
From The Lancet
"The premature commercialization of germline editing is creating a deregulated eugenics market. The risks of pleiotropy and off-target mutations in early embryonic stages result in an alarming rate of cell discard. We urge an immediate global moratorium before genetic modification becomes a tool of insurmountable biosocial stratification."
Editorial reading
The publication of this report in The Lancet tears the veil of one of the darkest and most destructive projects of late modernity: the absolute commodification of human life at its most vulnerable stage. Under the technocratic euphemism of "genetic improvement", we witness the resurgence of a deeply elitist eugenics, now stripped of the brutality of the totalitarian regimes of the twentieth century, but dressed in the aseptic and shiny suit of commercial biotechnology. The attempt to edit the embryonic genome for aesthetic or cognitive purposes constitutes the culmination point of philosophical immanentism: the excessive arrogance of a civilization that, after having denied the existence of Natural Law, establishes itself as the creator and absolute owner of the human being.
From a rigorous ontological and bioethical perspective, the seriousness of these practices transcends simple clinical recklessness. The embryos that the industry discards with impunity due to inevitable "off-target" mutations are not accumulations of fungible biological material; They are human persons in the first act, endowed with an intrinsic and infinite dignity. Reducing the generation of human life to industrial quality control, where the individual is evaluated, modified and eventually discarded according to the whims of the market and efficiency metrics, is the absolute denial of the inalienable value of the person. Each human being is a unique treasure, and their existence cannot be subject to the standards of perfection designed by an elite with purchasing power.
The attempt to manipulate the genome in its germline exposes a monumental ignorance about the immense complexity of biological systems, a myopic reductionism that assumes that the human genome functions as a simple linear software where instructions can be cut and pasted without disturbing the very delicate network of pleiotropic interactions. Quantum physics and systems biology have demonstrated endlessly that living organisms operate under principles of holistic causality. The arrogant manipulation of this natural balance always produces catastrophic consequences, empirically demonstrating that when man attempts to usurp the natural order, the inevitable result is the systematic and logical destruction of his own environment and his own species.
This Dantesque scenario of biosocial stratification warns us that science, divorced from right reason and realistic metaphysics, quickly becomes an instrument of oppression. True science has always been the amazed study of the created work, recognizing insurmountable ethical limits dictated by human nature itself. We require something much deeper than the simple global moratorium requested by the authors of the study; We need urgent moral restoration. It is imperative to return to an anthropology that recognizes that the dignity of man lies not in his biological perfection or his improved cognitive abilities, but in his nature itself, a nature that demands absolute respect from the moment of his conception to his natural end.
LEGAL NOTICE OF INTELLECTUAL PROPERTY AND FAIR USE
The editorial analysis and critical refutation constitute an original intellectual work by Editorial Santa Jacinta (DNDA Registry File No. RL-2026-42754029-APN-DNDA#MJ). The critical analysis of sources and the reproduction of extracts are carried out under the protection of Art. 28 (news of general interest) and Art. 10 (right to quote) of Law 11.723 on Intellectual Property of the Argentine Republic and the Berne Convention. Copyright over the original journalistic work belongs to The Lancet, properly linked. The partial informative quotation or reproduction of the editorial analysis is authorized, obligatorily citing the source («Editorial Santa Jacinta») with an active link to https://santajacinta.com.ar/relectura/ingenieria-embrionaria-mercantilizacion-genoma-thelancet.